Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Davis R. Ingram is active.

Publication


Featured researches published by Davis R. Ingram.


ACS Nano | 2009

Small multifunctional nanoclusters (Nanoroses) for targeted cellular imaging and therapy

Li Leo Ma; Marc D. Feldman; Jasmine M. Tam; Amit S. Paranjape; Kiran K. Cheruku; Timothy Larson; Justina O. Tam; Davis R. Ingram; Vidia Paramita; Joseph W. Villard; James T. Jenkins; Tianyi Wang; Geoffrey D. Clarke; Reto Asmis; Konstantin Sokolov; Bysani Chandrasekar; Thomas E. Milner; Keith P. Johnston

The ability of 20-50 nm nanoparticles to target and modulate the biology of specific types of cells will enable major advancements in cellular imaging and therapy in cancer and atherosclerosis. A key challenge is to load an extremely high degree of targeting, imaging, and therapeutic functionality into small, yet stable particles. Herein we report approximately 30 nm stable uniformly sized near-infrared (NIR) active, superparamagnetic nanoclusters formed by kinetically controlled self-assembly of gold-coated iron oxide nanoparticles. The controlled assembly of nanocomposite particles into clusters with small primary particle spacings produces collective responses of the electrons that shift the absorbance into the NIR region. The nanoclusters of approximately 70 iron oxide primary particles with thin gold coatings display intense NIR (700-850 nm) absorbance with a cross section of approximately 10(-14) m(2). Because of the thin gold shells with an average thickness of only 2 nm, the r(2) spin-spin magnetic relaxivity is 219 mM(-1) s(-1), an order of magnitude larger than observed for typical iron oxide particles with thicker gold shells. Despite only 12% by weight polymeric stabilizer, the particle size and NIR absorbance change very little in deionized water over 8 months. High uptake of the nanoclusters by macrophages is facilitated by the dextran coating, producing intense NIR contrast in dark field and hyperspectral microscopy, both in cell culture and an in vivo rabbit model of atherosclerosis. Small nanoclusters with optical, magnetic, and therapeutic functionality, designed by assembly of nanoparticle building blocks, offer broad opportunities for targeted cellular imaging, therapy, and combined imaging and therapy.


ACS Nano | 2010

Controlled Assembly of Biodegradable Plasmonic Nanoclusters for Near-Infrared Imaging and Therapeutic Applications

Jasmine M. Tam; Justina O. Tam; Avinash Murthy; Davis R. Ingram; Li Leo Ma; Kort Travis; Keith P. Johnston; Konstantin Sokolov

Metal nanoparticles with surface plasmon resonance (SPR) in the near-infrared region (NIR) are of great interest for imaging and therapy. Presently, gold nanoparticles with NIR absorbance are typically larger than 50 nm, above the threshold size of approximately 5 nm required for efficient renal clearance. As these nanoparticles are not biodegradable, concerns about long-term toxicity have restricted their translation into the clinic. Here, we address this problem by developing a flexible platform for the kinetically controlled assembly of sub-5 nm ligand-coated gold particles to produce metal/polymer biodegradable nanoclusters smaller than 100 nm with strong NIR absorbance for multimodal application. A key novel feature of the proposed synthesis is the use of weakly adsorbing biodegradable polymers that allows tight control of nanocluster size and, in addition, results in nanoclusters with unprecedented metal loadings and thus optical functionality. Over time, the biodegradable polymer stabilizer degrades under physiological conditions that leads to disassembly of the nanoclusters into sub-5 nm primary gold particles which are favorable for efficient body clearance. This synthesis of polymer/inorganic nanoclusters combines the imaging contrast and therapeutic capabilities afforded by the NIR-active nanoparticle assembly with the biodegradability of a polymer stabilizer.


Nature Genetics | 2014

Recurrent PTPRB and PLCG1 mutations in angiosarcoma

Sam Behjati; Patrick Tarpey; Helen Sheldon; Inigo Martincorena; Peter Van Loo; Gunes Gundem; David C. Wedge; Manasa Ramakrishna; Susanna L. Cooke; Nischalan Pillay; Hans Kristian Moen Vollan; Elli Papaemmanuil; Hans Koss; Tom D. Bunney; Claire Hardy; Olivia Joseph; Sancha Martin; Laura Mudie; Adam Butler; Jon Teague; Meena Patil; Graham Steers; Yu Cao; Curtis Gumbs; Davis R. Ingram; Alexander J. Lazar; Latasha Little; Harshad S. Mahadeshwar; Alexei Protopopov; Ghadah A. Al Sannaa

Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to ionizing radiation or chronic lymphoedema. Previous work has identified aberrant angiogenesis, including occasional somatic mutations in angiogenesis signaling genes, as a key driver of angiosarcoma. Here we employed whole-genome, whole-exome and targeted sequencing to study the somatic changes underpinning primary and secondary angiosarcoma. We identified recurrent mutations in two genes, PTPRB and PLCG1, which are intimately linked to angiogenesis. The endothelial phosphatase PTPRB, a negative regulator of vascular growth factor tyrosine kinases, harbored predominantly truncating mutations in 10 of 39 tumors (26%). PLCG1, a signal transducer of tyrosine kinases, encoded a recurrent, likely activating p.Arg707Gln missense variant in 3 of 34 cases (9%). Overall, 15 of 39 tumors (38%) harbored at least one driver mutation in angiogenesis signaling genes. Our findings inform and reinforce current therapeutic efforts to target angiogenesis signaling in angiosarcoma.


Optics Letters | 2012

Noncontact measurement of elasticity for the detection of soft-tissue tumors using phase-sensitive optical coherence tomography combined with a focused air-puff system

Shang Wang; Jiasong Li; Ravi Kiran Manapuram; Floredes M. Menodiado; Davis R. Ingram; Michael D. Twa; Alexander J. Lazar; Dina Lev; Raphael E. Pollock; Kirill V. Larin

We report on an optical noncontact method for the detection of soft-tissue tumors based on the measurement of their elasticity. A focused air-puff system is used to excite surface waves (SWs) on soft tissues with transient static pressure. A high-speed phase-sensitive optical coherence tomography system is used to measure the SWs as they propagate from the point of excitation. To evaluate the stiffness of soft tissues, the Youngs modulus is quantified based on the group velocity of SWs. Pilot experiments were performed on ex vivo human myxoma and normal fat. Results demonstrate the feasibility of the proposed method to measure elasticity and differentiate soft-tissue tumors from normal tissues.


Cancer Research | 2014

Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells

Arun Satelli; Abhisek Mitra; Jeffry Cutrera; Marcos Devarie; Xueqing Xia; Davis R. Ingram; Denada Dibra; Neeta Somaiah; Keila E. Torres; Vinod Ravi; Joseph A. Ludwig; Eugenie S. Kleinerman; Shulin Li

To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for detection of CTCs in peripheral blood of patients with cancer for epithelial cancers. Here, we report cell-surface vimentin (CSV) as an exclusive marker on sarcoma CTC regardless of the tissue origin of the sarcoma as detected by a novel monoclonal antibody. Utilizing CSV as a probe, we isolated and enumerated sarcoma CTCs with high sensitivity and specificity from the blood of patients bearing different types of sarcoma, validating their phenotype by single cell genomic amplification, mutation detection, and FISH. Our results establish the first universal and specific CTC marker described for enumerating CTCs from different types of sarcoma, thereby providing a key prognosis tool to monitor cancer metastasis and relapse.


Langmuir | 2010

Kinetic assembly of near-IR-active gold nanoclusters using weakly adsorbing polymers to control the size.

Jasmine M. Tam; Avinash Murthy; Davis R. Ingram; Robin Nguyen; Konstantin Sokolov; Keith P. Johnston

Clusters of metal nanoparticles with an overall size of less than 100 nm and high metal loadings for strong optical functionality are of interest in various fields including microelectronics, sensors, optoelectronics, and biomedical imaging and therapeutics. Herein we assemble approximately 5 nm gold particles into clusters with controlled size, as small as 30 nm and up to 100 nm, that contain only small amounts of polymeric stabilizers. The assembly is kinetically controlled with weakly adsorbing polymers, PLA(2K)-b-PEG(10K)-b-PLA(2K) or PEG (MW = 3350), by manipulating electrostatic, van der Waals (VDW), steric, and depletion forces. The cluster size and optical properties are tuned as a function of particle volume fractions and polymer/gold ratios to modulate the interparticle interactions. The close spacing between the constituent gold nanoparticles and high gold loadings (80-85 w/w gold) produce a strong absorbance cross section of approximately 9 x 10(-15) m(2) in the NIR at 700 nm. This morphology results from VDW and depletion attractive interactions that exclude the weakly adsorbed polymeric stabilizer from the cluster interior. The generality of this kinetic assembly platform is demonstrated for gold nanoparticles with a range of surface charges from highly negative to neutral with the two different polymers.


American Journal of Clinical Pathology | 2015

Extensive Survey of STAT6 Expression in a Large Series of Mesenchymal Tumors

Elizabeth G. Demicco; Paul W. Harms; Rajiv M. Patel; Steven C. Smith; Davis R. Ingram; Keila E. Torres; Shannon Carskadon; Sandra Camelo-Piragua; Jonathan B. McHugh; Javed Siddiqui; Nallasivam Palanisamy; David R. Lucas; Alexander J. Lazar; Wei Lien Wang

OBJECTIVES Expression of strong nuclear STAT6 is thought to be a specific marker for solitary fibrous tumors (SFTs). Little is known about subtle expression patterns in other mesenchymal lesions. METHODS We performed immunohistochemical studies against the C-terminus of STAT6 in tissue microarrays and whole sections, comprising 2366 mesenchymal lesions. RESULTS Strong nuclear STAT6 was expressed in 285 of 2,021 tumors, including 206 of 240 SFTs, 49 of 408 well-differentiated/dedifferentiated liposarcomas, eight of 65 unclassified sarcomas, and 14 of 184 desmoid tumors, among others. Expression in SFTs was predominately limited to the nucleus. Other positive tumors typically expressed both nuclear and cytoplasmic STAT6. Complete absence of STAT6 was most common in pleomorphic liposarcoma and alveolar soft part sarcoma (60% and 72% cases negative, respectively). CONCLUSIONS Strong nuclear STAT6 is largely specific for SFTs. Physiologic low-level cytoplasmic/nuclear expression is common in mesenchymal neoplasia and is of uncertain significance.


Modern Pathology | 2016

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival

Arjen H. G. Cleven; Ghadah A. Al Sannaa; Inge H. Briaire-de Bruijn; Davis R. Ingram; Matt van de Rijn; Brian P. Rubin; Maurits de Vries; Kelsey L. Watson; Kelia E. Torres; Wei Lien Wang; Sjoerd G. van Duinen; Pancras C.W. Hogendoorn; Alexander J. Lazar; Judith V. M. G. Bovée

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas that can show overlapping features with benign neurofibromas as well as high-grade sarcomas. Additional diagnostic markers are needed to aid in this often challenging differential diagnosis. Recently mutations in two critical components of the polycomb repressor 2 (PRC2) complex, SUZ12 and EED, were reported to occur specifically in MPNSTs while such mutations are absent in neurofibromas, both in the setting of neurofibromatosis (NF) and sporadic cases. Furthermore, both SUZ12 and EED mutations in MPNSTs were associated with loss of H3K27 tri-methylation, a downstream target of PRC2. Therefore, we tested whether H3K27me3 immunohistochemistry is useful as a diagnostic and prognostic marker for MPNSTs. We performed H3K27me3 immunohistochemistry in 162 primary MPNSTs, 97 neurofibromas and 341 other tumors using tissue microarray. We observed loss of H3K27me3 in 34% (55/162) of all MPNSTs while expression was retained in all neurofibromas including atypical (n=8) and plexiform subtypes (n=24). Within other tumors we detected loss of H3K27me3 in only 7% (24/341). Surprisingly, 60% (9/15) of synovial sarcomas and 38% (3/8) of fibrosarcomatous dermatofibrosarcoma protuberans (DFSP) showed loss of H3K27 trimethylation. Only 1 out of 44 schwannomas showed loss of H3K27me3 and all 4 perineuriomas showed intact H3K27me3. Furthermore, MPNSTs with loss of H3K27 tri-methylation showed inferior survival compared with MPNSTs with intact H3K27 tri-methylation, which was validated in two independent cohorts. Our results indicate that H3K27me3 immunohistochemistry is useful as a diagnostic marker, in which loss of H3K27me3 favors MPNST above neurofibroma. However, H3K27me3 immunohistochemistry is not suitable to distinguish MPNST from its morphological mimicker synovial sarcoma or fibrosarcomatous DFSP. Since loss of H3K27 tri-methylation was related to poorer survival in MPNST, chromatin modification mediated by this specific histone seems to orchestrate more aggressive tumour biology.


Cancer | 2013

Localized and metastatic myxoid/round cell liposarcoma: Clinical and molecular observations

Aviad Hoffman; Markus P. Ghadimi; Elizabeth G. Demicco; Chad J. Creighton; Keila E. Torres; Chiara Colombo; Tingsheng Peng; Kristelle Lusby; Davis R. Ingram; Jason L. Hornick; Wei Lie Wang; Vinod Ravi; Alexander J. Lazar; Dina Lev; Raphael E. Pollock

Myxoid liposarcoma (MLPS), a disease especially of young adults with potential for local recurrence and metastasis, currently lacks solid prognostic factors and therapeutic targets. The authors of this report evaluated the natural history and outcome of patients with MLPS and commonly deregulated protein biomarkers.


Journal of Colloid and Interface Science | 2010

Superparamagnetic nanoclusters coated with oleic acid bilayers for stabilization of emulsions of water and oil at low concentration

Davis R. Ingram; Csaba Kotsmar; Ki Youl Yoon; Stephen Shao; Chun Huh; Steven L. Bryant; Thomas E. Milner; Keith P. Johnston

Emulsions of water and dodecane with drop sizes down to 1 microm were stabilized with 30-100 nm interfacially active nanoclusters of sub-15 nm iron oxide primary particles at an extremely low loading of 0.14 wt.%. The nanoclusters, coated with a bilayer of oleic acid, formed stable dispersions in water at pH 7-10. The phase behavior and droplet morphologies of the emulsions of water and dodecane were tuned with pH. The oil/water emulsions at pH 9-10 were converted to middle phase emulsions at pH 6-7 and water/oil emulsions as the pH was further lowered. The magnetization per gram of Fe is similar for the nanoclusters and the primary particles, indicating the spacing between the particles is sufficient to avoid magnetic coupling. The larger volume of nanoclusters relative to the individual primary particles is beneficial for magnetomotive sensing applications including imaging of oil reservoirs, as it increases the force on the particles for a given magnetic field.

Collaboration


Dive into the Davis R. Ingram's collaboration.

Top Co-Authors

Avatar

Alexander J. Lazar

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Keila E. Torres

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Dina Lev

Sheba Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wei Lien Wang

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Ghadah A. Al Sannaa

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Wei-Lien Wang

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Elizabeth G. Demicco

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Jason L. Hornick

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Keith P. Johnston

University of Texas at Austin

View shared research outputs
Researchain Logo
Decentralizing Knowledge